|

Lenvatinib tablet Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Lenvima

Pipeline

Early 1: 1

Top Sponsors

  • Abramson Cancer Center at Penn Medicine1

Indications

  • Renal Cell Carcinoma1
  • Cancer1

Philadelphia, Pennsylvania1 trial

Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma

Abramson Cancer Center at University of Pennsylvania

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.